Mathias Lang, Ph.D Email & Phone Number
@superdimension.com
1 phone found area 763
LinkedIn matched
Who is Mathias Lang, Ph.D? Overview
A concise factual answer block for searchers comparing this professional profile.
Mathias Lang, Ph.D is listed as Founder and President at Medthias, based in Ghent Metropolitan Area, Belgium, Belgium. AeroLeads shows a work email signal at superdimension.com, phone signal with area code 763, and a matched LinkedIn profile for Mathias Lang, Ph.D.
Mathias Lang, Ph.D previously worked as Founder & President at Medthias and Chairman of the Board at Macropus Cvba & Wooncocoon Cvba. Mathias Lang, Ph.D holds Phd, Biology from The University Of Bonn.
Email format at Medthias
This section adds company-level context without repeating Mathias Lang, Ph.D's masked contact details.
AeroLeads found 2 current-domain work email signals for Mathias Lang, Ph.D. Compare company email patterns before reaching out.
About Mathias Lang, Ph.D
Mathias Lang, Ph.DDe Heide 4, B-9831 Deurle (St. Martens Latem) - BelgiumMOBILE: +32.475.600.188 - mlang9831@icloud.comNATIONALITY: 1959-65: Germany; 1966-2012: USA; 2013 to present: BelgiumSTATUS: Born in Edenkoben, Germany; March 20, 1959; Married; with 2 children.ACADEMIC BACKGROUND:•1977: High School Ghent, Belgium.•1981: Bachelor of Science in Applied Arts and Sciences - Degree in Zoology @ San Diego State University, San Diego, California.•1987: Master of Arts Degree in Biology (Emphasis: Evolutionary Biology & Systematics) @ SDSU, San Diego, California (Grade point average 3.8/4.0).•1989: Doctoral Degree in Biology @ Rheinische Friedrich Wilhelms Universität & Museum Alexander Koenig, Bonn (Grade: Summa Cum Laude).Dec 2014 - Present: President @ Medthias - MEDical Technologies Introduction & Support in Europe. Jan 2006 - Nov 2014: International VP & GM EUROPE superDimension; EM Lung Navigation. •Sep 2003 – Jan 2006: WW Vice President Strategic Planning & General Manager EU, member of senior management board of Impulse Dynamics and MetaCure. ID therapy for Heart Failure patients. MC for the treatment of type II Diabetes and Obesity. •Sep 2002 – Sep 2003: CEO@ vasopharm BIOTECH German pharmaceutical start-up company.•Oct 1997 – Sep 2002: Executive Director Market Development @ Biosense Webster – J&J, a company specializing in Electrophysiology .Feb. 1996 – Oct 1997. GM Biosense Europe R&D company intrabody navigational technologies. (Oct 1997: Acquisition of Biosense by J&J for 483 M$).•Dec 1994 - Jan 1996: Director Sales&Marketing New Business, Cordis Corporation (Europe), emphasis in Cardiology, Electrophysiology and Neurology. (Jan 1996: Acquisition of Cordis Corp. by J&J; 1.8 B $). •Dec. 1992 - Nov. 1994: GM / S&M Manager Europe for Uroplasty, microimplants for treatment of stress incontinence and vesicoureteral reflux. •Oct 1989 - Nov 1992: Sales Manager Benelux of Bioplasty, implants and devices for Plastic & Reconstructive Surgery.Specialties: Biotech Start-up companies in Europe in the fields of Cardiology; Electrophysiology and Intervention al Pulmonology
Listed skills include Medical Devices, Market Development, Cardiology, Start Ups, and 20 others.
Mathias Lang, Ph.D's current company
Company context helps verify the profile and gives searchers a useful next step.
Mathias Lang, Ph.D work experience
A career timeline built from the work history available for this profile.
Founder & President
Current- November 2014 – present:MEDical TecHnologies Introduction And Support (MEDTHIAS) is a company that introduces, markets, sells and supports (Clinical and Technical) start-up companies and their medical technologies in.
Chairman Of The Board
- December 2013 - 2016: Chairman of the Board of WooncocooN Cvba. WooncocooN is a non-profit organization with as goal the acquisition and management of a living center for local special needs young adults wanting to.
- June 2008- December 2013:Honorary Chairman of the Board of Macropus Cvba. Macropus is a non-profit organization with as goal the support of organizations helping families of special needs children in East Flanders.
International Vice President/General Mgr Europe
- January 2006 - November 2014:(May 2012: Acquisition of superDimension by Covidien for 365 M$).(November 2014: Acquisition of Covidien by Medtronic PLC for 43 B$ - Non-compete clause for all Medtronic and Covidien.
- Managing and directing of all activities of superDimension in Europe.
- Managing the activities of superDimension personnel and sales and marketing activities direct in Germany, France, UK, The Netherlands in addition to 14 distributors in EMEA.
- Develop and execute plans for sales, marketing and public relations activities associated with superDimension.
- Maintain pricing and reimbursement policies in 14 EMEA countries.
- Solidify relations with key Pulmonologists in the area of diagnostic, staging and Interventional Pulmonology as it relates to electro-magnetic pulmonary navigation.
Ww Vice President And General Manager Emea
WW Vice President of Strategic Planning & General Manager Europe, member of senior management board of Impulse Dynamics and MetaCure. Impulse Dynamics has a platform technology of implantable devices for the modulation of non-excitatory cells. For Cardiology (Impulse Dynamics) the therapy involves treatment of Heart Failure patients. MetaCure is developing.
Ceo
- September 2002 – September 2003:(September 2003: Completion of 1 year non-competition clause of Johnson&Johnson).Chief Executive Officer @ vasopharm BIOTECH GmbH, Würzburg, Germany. vasopharm BIOTECH is a venture.
- Series B Business Plan completion, road show and presentations at international Venture Capital and Biotech partnering meetings.
- Consolidation of two R&D labs into a single operational site with cost reduction and no loss of intellectual capacities or hindrance in project progress.
- Optimization of workflow and project planning, internal and external communications.
- Intellectual Property leveraging.
- Negotiations of co-operation and research agreements.
Executive Director
- October 1997 – October 2002:(October 1997: Acquisition of Biosense by Johnson & Johnson for 483 M$).(October 2002: Move to vasoPharm)Executive Director Market Development @ Biosense Webster – Johnson&Johnson, Waterloo.
- Development the 18 Biosense Webster Sales and Marketing organizations within JNJ in 25 EMEA countries.
- Responsibility for overall business plan for “Biosense Webster Umbrella (EMEA) Organisation”, with analysis, development and implementation of country-by-country programs to maximise sales and reimbursement in each.
- Hiring and training of 22 individuals including Country Managers and Clinical Sales Specialists.
- Achievement of 18 M$ of sales in 2001 with 35% operational growth versus 2000 in Electrophysiological products (capital equipment and disposables).
- Achievement of 33.3 M$ of sales in 2002 with 85% operational growth versus 2001 in Electrophysiological products (capital equipment and disposables).
Vice President & General Manager Europe
- February. 1996 – October 1997: (January 1996: Acquisition of Cordis Corp. by Johnson&Johnson; 1.8 B $).(October 1997: Acquisition of Biosense by Johnson & Johnson for 483 M$).General Manager for Biosense Europe, Ghent.
- Establishment of European Headquarters in Belgium as European clinical and Technical support organisation for coverage in all EEC countries.
- P&L management; Business development for new indications for intrabody navigational technologies.
- Co-ordination and development of clinical investigations and clinical research programs as well as the development of marketing materials, strategies and sales support for Biosense technologies.
- Organization of clinical meetings and key-opinion leader advisory meetings and Congresses.
- Advisor for R&D Department in Haifa for product modifications and new product developments.
Director Sales & Marketing New Business
- Dec. 1994 - Jan. 1996: (January 1996: Acquisition of Cordis Corp. by Johnson&Johnson; 1.8 B $).Director Sales & Marketing New Business, Cordis Corporation (Europe), Waterloo, Belgium. International Biomedical Company.
- European Sales and Marketing activities & European pricing strategies.
- P&L management with forecast and planning.
- Input for new product developments and modifications.
- Clinical trial management.
- Member of due diligence team for acquisitions and active member of Advanced Research and Development Council.
General Manager Europe
- Dec. 1992 - Nov. 1994:(Dec 1994 move to Cordis)General Manager / Sales & Marketing Manager Europe for Uroplasty Inc., Maastricht, The Netherlands, an international Urology company focused on microimplants for the.
- Restructuring of four European subsidiaries (after Chapter 14).
- Sales and Marketing Manager for European subsidiaries and worldwide dealer network.
- Expansion of product portfolio.
- Organization of international symposia.
- Clinical advisor for R&D department (Minneapolis, Minn.).
Sales Manager Benelux
- Oct. 1989 - Nov. 1992:(Q3 1992 FDA ruling on breast implants: Chapter 14 for Bioplasty restructured as Uroplasty)Sales Manager Benelux of Bioplasty Bvba, Breda, The Netherlands, a subsidiary of an international leader.
- Sales management and key opinion leader contact.
- P&L management; promotion and recruitment of new personnel.
- Clinical training and follow-up as well as clinical monitoring.
- Registration and reimbursement of new products with the Belgian and Dutch Health Ministries.
Researcher & Lecturer
- ACADEMIC WORK EXPERIENCE:
- Lecturer in Human Anatomy with co-ordination of dissection practica (San Diego State University & University of Kansas, Lawrence) 1981-1987.
- Assistant Curator of Herpetology - San Diego Natural History Museum & Museum of Natural History, University of Kansas; 1981-1987.
- Research Associate @ Museum Alexander Koenig, Bonn & Royal Institute of Natural Sciences, Brussels; 1988-1994.
Mathias Lang, Ph.D education
Frequently asked questions about Mathias Lang, Ph.D
Quick answers generated from the profile data available on this page.
What company does Mathias Lang, Ph.D work for?
Mathias Lang, Ph.D works for Medthias.
What is Mathias Lang, Ph.D's role at Medthias?
Mathias Lang, Ph.D is listed as Founder and President at Medthias.
What is Mathias Lang, Ph.D's email address?
AeroLeads has found 2 work email signals at @superdimension.com for Mathias Lang, Ph.D at Medthias.
What is Mathias Lang, Ph.D's phone number?
AeroLeads has found 1 phone signal(s) with area code 763 for Mathias Lang, Ph.D at Medthias.
Where is Mathias Lang, Ph.D based?
Mathias Lang, Ph.D is based in Ghent Metropolitan Area, Belgium, Belgium while working with Medthias.
What companies has Mathias Lang, Ph.D worked for?
Mathias Lang, Ph.D has worked for Medthias, Macropus Cvba & Wooncocoon Cvba, Superdimension, Impulse Dynamics, and Vasopharm Biotech Gmbh.
How can I contact Mathias Lang, Ph.D?
You can use AeroLeads to view verified contact signals for Mathias Lang, Ph.D at Medthias, including work email, phone, and LinkedIn data when available.
What schools did Mathias Lang, Ph.D attend?
Mathias Lang, Ph.D holds Phd, Biology from The University Of Bonn.
What skills is Mathias Lang, Ph.D known for?
Mathias Lang, Ph.D is listed with skills including Medical Devices, Market Development, Cardiology, Start Ups, Product Launch, Fda, Pulmonology, and Capital Equipment.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Mathias Lang, Ph.D you were looking for.
View similar profiles